Anzeige

2009: 102/2 (Aug) pp. 183-420

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

31 articles
1.
Genetic variants and risk for venous thromboembolic events: Summing up the evidence

Daniel Kurnik1,3; Aaron Lubetsky2,3

1Division of Clinical Pharmacology and Toxicology, and Department of Medicine A, Chaim Sheba Medical Center, Tel Hashomer, Israel; 2National Hemophilia Center and Institute of Thrombosis and Hemostasis, Department of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel; 3Sackler Faculty of Medicine, Tel Aviv University, Israel

Thrombosis and Haemostasis 2009 102 2: 183-184

http://dx.doi.org/10.1160/TH09-06-0350

[Summary] [Free download]
2.
The endothelium and thrombotic risk in heart failure

Eduard Shantsila; Gregory Y. H. Lip

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK

Thrombosis and Haemostasis 2009 102 2: 185-187

http://dx.doi.org/10.1160/TH09-06-0344

[Summary] [Free download]
3.
Frontiers of vascular biology: Mechanisms of inflammation and immunoregulation during arterial remodelling

Christian Weber

Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 188-190

http://dx.doi.org/10.1160/TH09-06-0371

[Summary] [Free download]
4.
Novel aspects in the regulation of the leukocyte adhesion cascade

Emmanouil Chavakis1; Eun Young Choi2; Triantafyllos Chavakis2

1Institute of Cardiovascular Regeneration, Dept. of Internal Medicine III, J.W. Goethe University Frankfurt, Frankfurt, Germany; 2Experimental Immunology Branch, NCI, NIH, Bethesda, Maryland, USA

Thrombosis and Haemostasis 2009 102 2: 191-197

http://dx.doi.org/10.1160/TH08-12-0844

[Summary] [Free download]
5.
Neutrophils launch monocyte extravasation by release of granule proteins

Oliver Soehnlein; Alma Zernecke; Christian Weber

Institute for Molecular Cardiovascular Research (IMCAR), RWTH University Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 198-205

http://dx.doi.org/10.1160/TH08-11-0720

[Summary] [Free download]
6.
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis

Dirk Lievens1; Wouter J. Eijgelaar1; Erik A. L. Biessen1; Mat J. A. P. Daemen1; Esther Lutgens1,2

1Experimental Vascular Pathology Division (EVP), Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM) University of Maastricht, The Netherlands; 2Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 206-214

http://dx.doi.org/10.1160/TH09-01-0029

[Summary] [Free download]
7.
How much is too much? Interleukin-6 and its signalling in atherosclerosis

Harald Schuett; Maren Luchtefeld; Christina Grothusen; Karsten Grote; Bernhard Schieffer

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

Thrombosis and Haemostasis 2009 102 2: 215-222

http://dx.doi.org/10.1160/TH09-05-0297

[Summary] [Free download]
8.
Effect of natural killer T cell activation on the initiation of atherosclerosis

Gijs H. M. van Puijvelde; Eva J. A. van Wanrooij; Arnaud D. Hauer; Paula de Vos; Theo J. C. van Berkel; Johan Kuiper

Division of Biopharmaceutics, LACDR/Leiden University, Leiden, the Netherlands

Thrombosis and Haemostasis 2009 102 2: 223-230

http://dx.doi.org/10.1160/TH09-01-0020

[Summary] [Free download]
9.
The vulnerable patient: Refocusing on the plaque?

Wouter J. Eijgelaar; Sylvia Heeneman; Mat J. A. P. Daemen

Experimental Vascular Pathology (EVP) Division, Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands

Thrombosis and Haemostasis 2009 102 2: 231-239

http://dx.doi.org/10.1160/TH09-01-0030

[Summary] [Free download]
10.
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury

Sabine Steffens*; Fabrizio Montecucco*; François Mach

Division of Cardiology, Foundation for Medical Researches, University Hospital, Geneva, Switzerland

Thrombosis and Haemostasis 2009 102 2: 240-247

http://dx.doi.org/10.1160/TH08-12-0837

[Summary] [Free download]
11.
Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis

Lisa K. Jennings

Vascular Biology Center of Excellence, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Thrombosis and Haemostasis 2009 102 2: 248-257

http://dx.doi.org/10.1160/TH09-03-0192

[Summary] [Free download]
12.
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence

Shaker A. Mousa1; Lars J. Petersen2

1The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA; 2Laboratory of Experimental Physiology & Inflammation, Department of Clinical Physiology, Viborg Hospital, Denmark

Thrombosis and Haemostasis 2009 102 2: 258-267

http://dx.doi.org/10.1160/TH08-12-0832

[Summary] [Free download]
13.
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

Gualtiero Palareti; Benilde Cosmi

Department of Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

Thrombosis and Haemostasis 2009 102 2: 268-278

http://dx.doi.org/10.1160/TH08-11-0730

[Summary] [Free download]
14.
[Add to basket]
Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis

Victor Gurewich; Ralph Pannell

Vascular Research Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 2: 279-286

http://dx.doi.org/10.1160/TH08-09-0598

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency

Rebecca E. Saunders1; Nuha Shiltagh1; Keith Gomez2; Gillian Mellars2; Carolyn Cooper3; David J. Perry3; Edward G. Tuddenham2; Stephen J. Perkins1

1Institute of Structural and Molecular Biology, University College London, London, UK; 2Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, Pond Street, London, UK; 3Department of Haematology, Addenbrookes Hospital, Hills Road, Cambridge, UK

Thrombosis and Haemostasis 2009 102 2: 287-301

http://dx.doi.org/10.1160/TH09-01-0044

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model

Leslie R. Berry1,2; Bruce Thong1,2; Anthony K. C. Chan1,2

1Henderson Research Centre, Hamilton, Ontario, Canada; 2Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2009 102 2: 302-308

http://dx.doi.org/10.1160/TH09-01-0062

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications

Giovanni Tiscia1; Donatella Colaizzo1; Elena Chinni1; Daniela Pisanelli1; Natale Sciannamè2; Giovanni Favuzzi1; Maurizio Margaglione1,3; Elvira Grandone1

1Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni R. (FG), University of Foggia, Foggia, Italy; 2 Obstetrics and Gynaecology, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni R. (FG), University of Foggia, Foggia, Italy; 3 Medical Genetics, University of Foggia, Foggia, Italy

Thrombosis and Haemostasis 2009 102 2: 309-313

http://dx.doi.org/10.1160/TH09-02-0123

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Prognostic impact of haemostatic derangements in chronic heart failure

Borut Jug1; Nina Vene1; Barbara Gužic Salobir2; Miran Šebeštjen1; Mišo Šabovic1; Irena Keber1

1Department of Vascular Diseases, Clinic of Internal Medicine, University Clinical Center Ljubljana, Slovenia; 2Clinic of Nuclear Medicine, University Clinical Center Ljubljana, Slovenia

Thrombosis and Haemostasis 2009 102 2: 314-320

http://dx.doi.org/10.1160/TH08-11-0721

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis

Alpesh N. Amin1; Jay Lin2; Greg Lenhart3; Kathy L. Schulman3

1University of California – Irvine, Orange, California, USA; 2sanofi-aventis, Bridgewater, New Jersey, USA; 3Healthcare, Thomson Reuters, Cambridge, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 2: 321-326

http://dx.doi.org/10.1160/TH09-03-0147

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3β in platelets

- See additional contents by clicking on [Summary] -

Hideki Hayashi; Toshiki Sudo

First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan

Thrombosis and Haemostasis 2009 102 2: 327-335

http://dx.doi.org/10.1160/TH08-12-0781

[Summary] [PDF] [Pay per view]
  1-20 21-31
Next page

Articles

You've 98 Article(s) in your Basket.

Thrombosis News

TH107.2

With the expiry or pending expiry of originator low-molecular-weight heparin (LMWH) patents,...

TH 107.1

T&H has a new type of article! Read the first T&H Insights article by Lutgens et al. in the...

TH 106.6

Read the important position document from the European Heart Rhythm Association [EHRA] and the...